title: Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting.
authors.affiliation: Hematology Unit, S. Eugenio Hospital, Rome, Italy.
authors.forename: Pasquale
authors.initials: P
authors.lastname: Niscola
authors.forename: Andrea
authors.initials: A
authors.lastname: Tendas
authors.forename: Luca
authors.initials: L
authors.lastname: Cupelli
authors.forename: Marco
authors.initials: M
authors.lastname: Giovannini
authors.forename: Daniela
authors.initials: D
authors.lastname: Piccioni
authors.forename: Laura
authors.initials: L
authors.lastname: Scaramucci
authors.forename: Teresa
authors.initials: T
authors.lastname: Dentamaro
authors.forename: Giovanni
authors.initials: G
authors.lastname: Del Poeta
authors.forename: Paolo
authors.initials: P
authors.lastname: de Fabritiis
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001374:Azacitidine / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality / Q000628:therapy; D015477:Leukemia, Myelomonocytic, Chronic / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000473:pathology*; D014184:Transplantation, Homologous; D017211:Treatment Failure
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine